Menu
Synergy in Action

15th Annual Scientific Meeting

19 – 21 February, 2019   //   The Fairmont, Washington DC

Preliminary Agenda

Point/Counterpoint
Question 1: Are patients with any degree of suicidality acceptable for inclusion in clinical trials?
                      Chair: Carla Canuso
Question 2: Are acute rapid onset anti-depressant results valid, or just a consequence of functional unblinding?
                      Chair: Stephen Brannan     

Disease Modification: Untangling and Resolving the Complex Challenges of Delayed-Start Designs
Chairs: Larry Alphs/Luca Pani

Methodological issues associated with the new Alzheimer’s Draft Guidance
Chairs: Adam Butler/Judy Jaeger

Finding the Signal: Strategies for achieving participant-centric trials in the face of participant-introduced validity challenges
Chairs: Sian Ratcliffe/Tim Mariano/Kari Nations

The Perils and Promise of Real-World Outcomes in Clinical Trials  
Chairs: Dawn Velligan/Rob Epstein

Poster Session (Guidelines and Submission Form)
Working Groups